RIZZOLIO, Flavio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.646
AS - Asia 11.312
EU - Europa 7.699
SA - Sud America 1.086
AF - Africa 234
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 20
Totale 43.020
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.199
CN - Cina 3.606
SG - Singapore 3.287
IT - Italia 2.048
VN - Vietnam 1.624
PL - Polonia 1.503
BR - Brasile 897
HK - Hong Kong 856
DE - Germania 701
IE - Irlanda 659
UA - Ucraina 556
SE - Svezia 465
GB - Regno Unito 452
JP - Giappone 407
FR - Francia 384
KR - Corea 354
CA - Canada 332
IN - India 325
RU - Federazione Russa 260
FI - Finlandia 195
TR - Turchia 174
BD - Bangladesh 106
AT - Austria 90
ID - Indonesia 89
ES - Italia 85
IQ - Iraq 83
MX - Messico 77
NL - Olanda 75
ZA - Sudafrica 73
PK - Pakistan 63
PH - Filippine 60
AR - Argentina 55
BE - Belgio 49
EC - Ecuador 45
TH - Thailandia 45
IR - Iran 42
BJ - Benin 33
CH - Svizzera 33
MA - Marocco 33
UZ - Uzbekistan 33
TW - Taiwan 29
JO - Giordania 24
VE - Venezuela 24
LT - Lituania 23
CO - Colombia 20
GR - Grecia 19
AU - Australia 18
CL - Cile 18
KE - Kenya 18
SA - Arabia Saudita 18
EU - Europa 17
BG - Bulgaria 13
EG - Egitto 13
DZ - Algeria 12
AE - Emirati Arabi Uniti 11
PT - Portogallo 11
PY - Paraguay 11
AL - Albania 10
CZ - Repubblica Ceca 10
DK - Danimarca 10
RO - Romania 10
TN - Tunisia 9
MY - Malesia 8
NG - Nigeria 8
SI - Slovenia 8
CR - Costa Rica 7
KZ - Kazakistan 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
IL - Israele 6
SN - Senegal 6
HR - Croazia 5
LB - Libano 5
NP - Nepal 5
NZ - Nuova Zelanda 5
OM - Oman 5
RS - Serbia 5
AM - Armenia 4
AZ - Azerbaigian 4
BH - Bahrain 4
GE - Georgia 4
HN - Honduras 4
JM - Giamaica 4
LR - Liberia 4
PE - Perù 4
QA - Qatar 4
UY - Uruguay 4
AO - Angola 3
BN - Brunei Darussalam 3
HU - Ungheria 3
KH - Cambogia 3
MM - Myanmar 3
NO - Norvegia 3
PA - Panama 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
Totale 42.972
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.154
Ashburn 2.886
Fairfield 2.164
Singapore 1.731
Warsaw 1.491
Chandler 1.391
Ann Arbor 1.154
Houston 1.146
Dallas 1.027
Seattle 953
San Jose 918
Jacksonville 858
Hong Kong 815
Cambridge 717
Wilmington 677
Dublin 592
Ho Chi Minh City 451
Hanoi 393
Beijing 340
Council Bluffs 329
Jinan 318
Seoul 314
New York 305
Tokyo 302
Mestre 284
Venice 270
Boardman 267
Nanjing 260
Dearborn 228
Shenyang 224
Guangzhou 203
Los Angeles 201
Venezia 196
The Dalles 185
Andover 184
Boston 170
Hefei 160
San Mateo 151
Mülheim 149
Hebei 139
Lauterbourg 139
Toronto 133
Izmir 129
Princeton 129
Ottawa 119
Munich 115
San Diego 115
Santa Clara 108
Hangzhou 104
São Paulo 101
Changsha 96
Tianjin 96
Zhengzhou 96
Frankfurt am Main 93
Helsinki 92
Columbus 89
Nanchang 89
Milan 88
Bengaluru 85
Orem 84
Taizhou 83
Altamura 81
Haikou 77
Jakarta 74
Da Nang 72
Padova 72
Taiyuan 71
London 70
Haiphong 66
Ningbo 60
Buffalo 59
Vienna 55
Jiaxing 54
Johannesburg 50
San Paolo di Civitate 50
Chicago 48
Brussels 46
Redondo Beach 45
Moscow 43
Nuremberg 43
Chennai 42
Redwood City 42
Pune 40
Fuzhou 39
Des Moines 38
Brooklyn 37
Shanghai 37
North Bergen 35
Cotonou 33
Montreal 33
Rio de Janeiro 32
Amsterdam 31
Menlo Park 31
Denver 29
Phoenix 29
Washington 29
Saint Petersburg 28
Baghdad 27
Rome 27
Atlanta 26
Totale 31.681
Salva come PNG Salva come JPEG
Nome #
Bottom-Up Synthesis of Carbon Nanoparticles with Higher Doxorubicin Efficacy 612
An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer 570
Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior? 550
Biocompatible tailored zirconia mesoporous nanoparticles with high surface area for theranostic applications 512
Highly conserved non-coding sequences and the 18q critical region for short stature: A common mechanism of disease? 478
Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects 461
Synthesis of new allyl palladium complexes bearing purine-based NHC ligands with antiproliferative and proapoptotic activity on human ovarian cancer cell lines 460
pRb controls estrogen receptor alpha protein stability and activity 447
Carbon-dots from sugars and ascorbic acid: Role of the precursors on morphology, properties, toxicity and drug uptake 439
A guide to PIN1 function and mutations across cancers 438
Enhanced Chemotherapeutic Behavior of Open-Caged DNA@Doxorubicin Nanostructures for Cancer Cells 436
The history of nanoscience and nanotechnology: From chemical-physical applications to nanomedicine 436
A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients 433
Hyaluronan esters drive smad gene expression and signaling enhancing cardiogenesis in mouse embryonic and human mesenchymal stem cells 433
Phamacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer 423
Glucose Detection Devices and Methods Based on Metal–Organic Frameworks and Related Materials 419
Recent advances of electrochemical and optical enzyme-free glucose sensors operating at physiological conditions 418
Palladacyclopentadienyl complexes bearing purine-based N-heterocyclic carbenes: A new class of promising antiproliferative agents against human ovarian cancer 416
An effective multi-stage liposomal DNA origami nanosystem for in vivo cancer therapy 413
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor 407
Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy 400
4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors 399
DNA nanotechnology for cancer therapy 397
The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor α in Breast Cancer 397
Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer research 393
Self-Therapeutic Nanomaterials for Cancer Therapy: A Review 389
The anticancer activity of an air-stable Pd(i)-NHC (NHC = N-heterocyclic carbene) dimer 389
Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer 387
Proof-of-Concept Multistage Biomimetic Liposomal DNA Origami Nanosystem for the Remote Loading of Doxorubicin 379
Synthesis and in-depth studies on the anticancer activity of novel palladacyclopentadienyl complexes stabilized by N-Heterocyclic carbene ligands 377
Androgen receptor serine 81 mediates Pin1 interaction and activity 370
Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression 368
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017) 357
Adenosine receptor ligands in clinical trials 329
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells 326
Palladium (0) olefin complexes bearing purine-based N-heterocyclic carbenes and 1,3,5-triaza-7-phosphaadamantane (PTA): Synthesis, characterization and antiproliferative activity toward human ovarian cancer cell lines 326
MTHFR-1298 A > C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 324
The Clinical translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes 324
Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy 323
A susceptibility gene for premature ovarian failure (POF) maps to proximal Xq28 322
A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males 318
Highly Selective Salicylketoxime-Based Estrogen Receptor beta Agonists Display Antiproliferative Activities in a Glioma Model 317
Allyl palladium complexes bearing carbohydrate-based N-heterocyclic carbenes: Anticancer agents for selective and potent in vitro cytotoxicity 317
Improved Synthesis, Anticancer Activity and Electrochemical Characterization of Unusual Zwitterionic Palladium Compounds with a Ten‐Term Coordinative Ring 316
Supercritical CO2 extraction of natural antibacterials from low value weeds and agro-waste 316
Identification and characterization of a new reversible MAGL inhibitor 314
Epigenetic analysis of the critical region I for premature ovarian failure: Demonstration of a highly heterochromatic domain on the long arm of the mammalian X chromosome 313
Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 308
The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation 306
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold 305
Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin 304
Pin1 and nuclear receptors: A new language? 301
Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1 300
Combined effects of PI3K and SRC kinase inhibitors with imatinib on intracellular calcium levels, autophagy, and apoptosis in CML-PBL cells 297
Chromosomal rearrangements in Xq and premature ovarian failure: Mapping of 25 new cases and review of the literature 294
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors 294
Osteopontin controls endothelial cell migration in vitro and in excised human valvular tissue from patients with calcific aortic stenosis and controls 291
Cyclic Ketoximes as Estrogen Receptor Selective Agonists 290
RB gene family: Genome-wide ChIP approaches could open undiscovered roads 289
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 288
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents 284
Metabolomics biomarkers of frailty in elderly breast cancer patients 283
Dissecting Pin1 and phospho-pRb regulation 280
CDK inhibitors: from the bench to clinical trials 280
Fluorescent carbon nanoparticles in medicine for cancer therapy 279
Synthesis and Antimicrobial Evaluation of Bis-morpholine Triazine Quaternary Ammonium Salts 278
Critical choices for modeling breast cancer in transgenic mouse models 277
Epigenetic control of the critical region for premature ovarian failure on autosomal genes translocated to the X chromosome: A hypothesis 277
Upconversion-mediated Boltzmann thermometry in double-layered Bi2SiO5:Yb3+,Tm3+@SiO2hollow nanoparticles 277
X chromosome and ovarian failure 276
Pharmaco-metabolomics: An emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets 275
STARD3: A Prospective Target for Cancer Therapy 274
Ubiquitin-mediated protein degradation and methylation-induced gene silencing cooperate in the inactivation of the INK4/ARF locus in Burkitt's lymphoma cell lines 271
Spatial and temporal expression of POF1B, a gene expressed in epithelia 271
Palladium(II)-η3-Allyl Complexes Bearing N-Trifluoromethyl N-Heterocyclic Carbenes: A New Generation of Anticancer Agents that Restrain the Growth of High-Grade Serous Ovarian Cancer Tumoroids 271
Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models 270
Silencing of RB1 but not of RB2/P130 induces cellular senescence and impairs the differentiation potential of human mesenchymal stem cells 268
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 268
Nanomedicine in cancer pathology 267
Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors 265
Fluorescent molecularly imprinted nanogels for the detection of anticancer drugs in human plasma 264
2D metal azolate framework as nanozyme for amperometric detection of glucose at physiological pH and alkaline medium 263
Emerging molecular networks in Burkitt's lymphoma 261
Identification of new fyn kinase inhibitors using a FLAP-based approach 260
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 257
Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer 254
Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors 252
Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer's Disease 252
Fluorescent Carbon Nanoparticles in Medicine for Cancer Therapy: An Update 252
Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)2NS) for Ovarian Cancer Therapy 252
Research highlights. Overcoming BRAF resistance to PLX4032 by AKT inhibition in PTEN-deficient melanoma cells 250
Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B 247
Application of MM-PBSA methods in virtual screening 243
A carrier free delivery system of a monoacylglycerol lipase hydrophobic inhibitor 243
Cancer extracellular vesicles: Next-generation diagnostic and drug delivery nanotools 242
Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer 238
Synthesis and comparative study of the anticancer activity of η3-allyl palladium(II) complexes bearing N-heterocyclic carbenes as ancillary ligands 235
Sustainable triazine-derived quaternary ammonium salts as antimicrobial agents 235
Inorganic Nanoparticles for Cancer Therapy: a Transition from Lab to Clinic 230
Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer 226
Totale 33.002
Salva come PNG Salva come JPEG
Categoria #
all - tutte 135.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.981
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.683 0 0 0 0 0 0 0 0 0 598 663 422
2021/20225.040 344 591 330 625 383 40 221 194 97 740 1.014 461
2022/20233.883 297 384 68 445 366 1.110 50 284 482 32 291 74
2023/20241.937 103 110 72 91 261 443 63 124 216 48 190 216
2024/20253.755 59 98 262 280 299 228 441 398 446 425 546 273
2025/202613.422 961 736 1.707 976 1.597 1.082 2.075 812 2.061 1.415 0 0
Totale 43.732